Intellia fine tunes its CRISPR/Cas9 tech ahead of human studies – Endpoints News
Endpoints News |
Intellia fine tunes its CRISPR/Cas9 tech ahead of human studies
Endpoints News One of the handful of gene therapy startups has been fine tuning its CRISPR/Cas9 tech in the lead up to taking it into humans. Building on preclinical work published last summer, investigators at Cambridge, MA-based Intellia $NTLA say they’ve … |
Defiance Crescent News (subscription) |
Researchers Study Cure for Type 1 Diabetes in Stem Cell Transplantations
Defiance Crescent News (subscription) DUARTE, Calif.–(BUSINESS WIRE)–Mar 7, 2017–Some type 1 diabetes (T1D) patients can be cured from the disease, at least for a number of years, with a stem cell transplant — those were the results of a clinical trial monitored by City of Hope’s Bart … Stem cell transplant findings could lead to personalised type 1 diabetes treatmentsDiabetes.co.uk |
MIT Technology Review |
The Download, Mar 8, 2017: CIA Leak Realism, Democratizing Gene Therapy, and Luxurious Smartphones
MIT Technology Review You probably can’t afford gene therapy—but a new lab-in-a-box may change that. Even though the technique is becoming a medical reality, most successful therapies require days of work by teams of world-class scientists in the multimillion-dollar clean … |
Seeker |
CRISPR Could Domesticate Wild Crops While Avoiding ‘Frankenfoods’
Seeker A team of plant biologists, ethicists and social scientists from the University of Copenhagen proposes to use CRISPR, the precision gene-editing technology, to rapidly domesticate wild plants. Tweaking the genes of wild foods could produce nutritious … |